The delisting risk is off the table for now, which is a positive catalyst for a micro-cap stock. Monitor the company's next 10-Q for equity levels to assess whether it can survive the one-year Mandatory Panel Monitor period. The G3 Vision Labs option agreement mentioned in the press release adds a potential business transformation catalyst.
Price Chart
Executive Summary
Profusa received a Nasdaq Compliance Determination Letter confirming it has regained compliance with the Bid Price Rule and Equity Rule, removing the immediate delisting risk. However, the company is now subject to a one-year Mandatory Panel Monitor, during which any failure to maintain the Equity Rule will result in an immediate Staff Delisting Determination without a cure period. This removes the near-term delisting overhang but imposes strict ongoing compliance conditions on a micro-cap company with a $1M market cap.
Key Facts
- Nasdaq confirmed Profusa has demonstrated compliance with Listing Rule 5550(a)(2) (Bid Price Rule) and Rule 5550(b)(1) (Equity Rule).
- Company is subject to a one-year Mandatory Panel Monitor; any future Equity Rule violation triggers an immediate Staff Delisting Determination with no cure period.
- Market cap is $1M, and the stock trades on Nasdaq under ticker PFSA.
Financial Impact
Removes immediate delisting risk; no financial figures disclosed in the filing.
Risk Factors
- Strict one-year Mandatory Panel Monitor with no cure period for any future Equity Rule violation.
- Micro-cap ($1M market cap) with limited financial resources to maintain compliance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-099871 |
| Document: ea030512101ex99-1.htm | 0001213900-26-099871 |
| Document: 0001213900-26-099871-index-headers.html | 0001213900-26-099871 |
| Document: 0001213900-26-099871-index.html | 0001213900-26-099871 |
| Document: 0001213900-26-099871.txt | 0001213900-26-099871 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | Press Release | $1.07 $1.02 | ▼ −4.67% | ▼ −3.66% | $0.7800 (−27.10%) |
Oct 15, 2026 11d ago | 8-K | $1.07 $1.02 | ▲ +4.67% | ▲ +3.66% | $0.7800 (+27.10%) |
Oct 9, 2026 17d ago | 8-K | $1.30 $0.9002 | ▲ +30.75% | ▲ +29.26% | $0.7800 (+40.00%) |
Oct 5, 2026 21d ago | 8-K | $1.75 $1.30 | ▼ −25.71% | ▼ −26.14% | $0.7800 (−55.43%) |
Sep 24, 2026 4w ago | Press Release | $3.03 $1.87 | ▼ −38.28% | ▼ −37.87% | $0.7800 (−74.26%) |
Sep 16, 2026 5w ago | 8-K | $1.78 $2.05 | ▼ −15.17% | ▼ −12.61% | $0.7800 (+56.18%) |
Sep 15, 2026 5w ago | 8-K | $1.83 $1.91 | ▲ +4.37% | ▲ +3.55% | $0.7800 (−57.38%) |
Sep 1, 2026 7w ago | 8-K | $2.88 $2.47 | ▲ +14.24% | ▲ +14.32% | $0.7800 (+72.92%) |
Aug 31, 2026 8w ago | 8-K | $3.00 $2.88 | ▼ −4.00% | ▼ −3.86% | $0.7800 (−74.00%) |
Aug 20, 2026 9w ago | 8-K | $7.57 $4.24 | ▲ +43.99% | ▲ +45.10% | $0.7800 (+89.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers